id	sid	eid	entity	type
gsrj-41	1	1	covid-19	PRODUCT
gsrj-41	1	2	the united states	GPE
gsrj-41	1	3	miranda wesley	PERSON
gsrj-41	1	4	two	CARDINAL
gsrj-41	1	5	two	CARDINAL
gsrj-41	1	6	2022	CARDINAL
gsrj-41	1	7	6	CARDINAL
gsrj-41	1	8	covid-19	ORG
gsrj-41	1	9	the united states	GPE
gsrj-41	1	10	wesley	PERSON
gsrj-41	1	11	georgetown university	ORG
gsrj-41	1	12	washington	GPE
gsrj-41	1	13	d.c.	GPE
gsrj-41	2	1	covid-19	PRODUCT
gsrj-41	3	1	covid-19	PERSON
gsrj-41	3	2	u.s.	GPE
gsrj-41	3	3	24%	PERCENT
gsrj-41	3	4	covid-19	PRODUCT
gsrj-41	4	1	covid-19	PRODUCT
gsrj-41	4	2	the united states	GPE
gsrj-41	5	1	27	CARDINAL
gsrj-41	6	1	88.89%	PERCENT
gsrj-41	6	2	59.25%	PERCENT
gsrj-41	7	1	58	CARDINAL
gsrj-41	7	2	458,235	CARDINAL
gsrj-41	8	1	u.s.	GPE
gsrj-41	8	2	25.9%	PERCENT
gsrj-41	8	3	u.s.	GPE
gsrj-41	8	4	37.0%	PERCENT
gsrj-41	8	5	u.s.	GPE
gsrj-41	8	6	22.2%	PERCENT
gsrj-41	8	7	14.8%	PERCENT
gsrj-41	9	1	covid-19	PRODUCT
gsrj-41	9	2	57.14%	PERCENT
gsrj-41	10	1	21.42%	PERCENT
gsrj-41	10	2	14.28%	PERCENT
gsrj-41	10	3	3.57%	PERCENT
gsrj-41	10	4	3.57%	PERCENT
gsrj-41	11	1	just over half	CARDINAL
gsrj-41	11	2	51.8%	PERCENT
gsrj-41	11	3	covid-19	PRODUCT
gsrj-41	11	4	37.0%	PERCENT
gsrj-41	11	5	11.1%	PERCENT
gsrj-41	12	1	covid-19	PRODUCT
gsrj-41	12	2	american	NORP
gsrj-41	17	1	covid-19	PERSON
gsrj-41	17	2	7	CARDINAL
gsrj-41	17	3	1	CARDINAL
gsrj-41	17	4	covid-19	PERSON
gsrj-41	17	5	the united states	GPE
gsrj-41	18	1	u.s.	GPE
gsrj-41	18	2	77 million	CARDINAL
gsrj-41	18	3	920,097	CARDINAL
gsrj-41	18	4	february 15	DATE
gsrj-41	18	5	2022.1	CARDINAL
gsrj-41	18	6	americans	NORP
gsrj-41	18	7	146,921	CARDINAL
gsrj-41	18	8	daily	DATE
gsrj-41	18	9	7-day	DATE
gsrj-41	18	10	around 2,208	CARDINAL
gsrj-41	18	11	7day	DATE
gsrj-41	18	12	february 15	DATE
gsrj-41	18	13	2021.1	CARDINAL
gsrj-41	18	14	covid-19	ORG
gsrj-41	18	15	u.s.	GPE
gsrj-41	18	16	johnson & johnson	ORG
gsrj-41	19	1	first	ORDINAL
gsrj-41	19	2	fda	ORG
gsrj-41	19	3	eua	PERSON
gsrj-41	19	4	covid-19	PRODUCT
gsrj-41	19	5	december 11	DATE
gsrj-41	19	6	2020.2	CARDINAL
gsrj-41	19	7	johnson & johnson	ORG
gsrj-41	19	8	ages 12 to 15 and 5 to 11	DATE
gsrj-41	19	9	may 10th	DATE
gsrj-41	19	10	october 29th	DATE
gsrj-41	19	11	2021	DATE
gsrj-41	19	12	fda	ORG
gsrj-41	19	13	august 23rd	DATE
gsrj-41	19	14	2021.2	CARDINAL
gsrj-41	19	15	fda	ORG
gsrj-41	20	1	1	CARDINAL
gsrj-41	20	2	u.s. covid-19	ORG
gsrj-41	20	3	december 2020 to	DATE
gsrj-41	20	4	2021.2	CARDINAL
gsrj-41	20	5	fda eua	PERSON
gsrj-41	20	6	december 11th, 2020	DATE
gsrj-41	21	1	8	CARDINAL
gsrj-41	21	2	three	CARDINAL
gsrj-41	21	3	covid-19	PERSON
gsrj-41	21	4	covid-19	PERSON
gsrj-41	21	5	seven	CARDINAL
gsrj-41	22	1	u.s.	GPE
gsrj-41	22	2	64.5%	PERCENT
gsrj-41	22	3	covid-19	PRODUCT
gsrj-41	22	4	76%	PERCENT
gsrj-41	22	5	at least one	CARDINAL
gsrj-41	22	6	february 15	DATE
gsrj-41	22	7	2022.6	CARDINAL
gsrj-41	22	8	24%	PERCENT
gsrj-41	22	9	one	CARDINAL
gsrj-41	22	10	asian	NORP
gsrj-41	22	11	3-5).8	CARDINAL
gsrj-41	22	12	40.2%	PERCENT
gsrj-41	22	13	47.6%	PERCENT
gsrj-41	22	14	u.s.	GPE
gsrj-41	23	1	cdc	ORG
gsrj-41	23	2	idaho	GPE
gsrj-41	23	3	west virginia	GPE
gsrj-41	23	4	the southeast region	LOC
gsrj-41	23	5	midwest	LOC
gsrj-41	23	6	2).10	CARDINAL
gsrj-41	24	1	december 2021	DATE
gsrj-41	24	2	81.9%	PERCENT
gsrj-41	24	3	only 69.3%	PERCENT
gsrj-41	24	4	2: percent	PERCENT
gsrj-41	24	5	at least one	CARDINAL
gsrj-41	24	6	us	GPE
gsrj-41	26	1	3: percent	PERCENT
gsrj-41	26	2	u.s.	GPE
gsrj-41	27	1	4: percent	PERCENT
gsrj-41	27	2	u.s.	GPE
gsrj-41	28	1	males.8 9	ORG
gsrj-41	28	2	georgetown scientific research journal	ORG
gsrj-41	28	3	5	CARDINAL
gsrj-41	28	4	u.s.	GPE
gsrj-41	29	1	the 77.6%	PERCENT
gsrj-41	30	1	asian	NORP
gsrj-41	30	2	59.5%	PERCENT
gsrj-41	30	3	american	NORP
gsrj-41	30	4	indian	NORP
gsrj-41	30	5	alaska	GPE
gsrj-41	30	6	58.0%	PERCENT
gsrj-41	30	7	native hawaiian	NORP
gsrj-41	30	8	pacific islander	LOC
gsrj-41	30	9	57.4%	PERCENT
gsrj-41	30	10	hispanic	NORP
gsrj-41	30	11	51.1%	PERCENT
gsrj-41	30	12	47.6%	PERCENT
gsrj-41	30	13	40.2%).8	CARDINAL
gsrj-41	30	14	13	CARDINAL
gsrj-41	30	15	covid-19	ORG
gsrj-41	31	1	covid-19	PERSON
gsrj-41	32	1	u.s.	GPE
gsrj-41	32	2	covid-19.14	ORG
gsrj-41	32	3	13	CARDINAL
gsrj-41	32	4	u.s.	GPE
gsrj-41	32	5	covid-19	ORG
gsrj-41	32	6	u.s.	GPE
gsrj-41	33	1	u.s.	GPE
gsrj-41	34	1	covid-19	PRODUCT
gsrj-41	36	1	2	CARDINAL
gsrj-41	36	2	covid-19	PRODUCT
gsrj-41	36	3	the united states	GPE
gsrj-41	36	4	september 1, 2021, to	DATE
gsrj-41	36	5	november 24, 2021	DATE
gsrj-41	37	1	2.1	CARDINAL
gsrj-41	37	2	u.s.	GPE
gsrj-41	40	1	around 24%	PERCENT
gsrj-41	40	2	u.s.	GPE
gsrj-41	40	3	one	CARDINAL
gsrj-41	40	4	covid-19	PRODUCT
gsrj-41	40	5	19.2%	PERCENT
gsrj-41	40	6	ages 5	DATE
gsrj-41	40	7	one	CARDINAL
gsrj-41	40	8	10	CARDINAL
gsrj-41	40	9	covid-19	PRODUCT
gsrj-41	40	10	u.s.	GPE
gsrj-41	41	1	1	CARDINAL
gsrj-41	41	2	covid-19	PRODUCT
gsrj-41	41	3	u.s.	GPE
gsrj-41	41	4	2	CARDINAL
gsrj-41	42	1	2.2	CARDINAL
gsrj-41	42	2	covid-19	ORG
gsrj-41	42	3	(united states	GPE
gsrj-41	45	1	38	CARDINAL
gsrj-41	45	2	27	CARDINAL
gsrj-41	46	1	the united states	GPE
gsrj-41	47	1	1	CARDINAL
gsrj-41	47	2	non-u.s	ORG
gsrj-41	47	3	4	CARDINAL
gsrj-41	47	4	non-covid-19	ORG
gsrj-41	47	5	2	CARDINAL
gsrj-41	47	6	2	CARDINAL
gsrj-41	47	7	1	CARDINAL
gsrj-41	47	8	1	CARDINAL
gsrj-41	48	1	38	CARDINAL
gsrj-41	49	1	27	CARDINAL
gsrj-41	52	1	3	CARDINAL
gsrj-41	52	2	27	CARDINAL
gsrj-41	52	3	americans	NORP
gsrj-41	53	1	3.1	CARDINAL
gsrj-41	53	2	59.25%	PERCENT
gsrj-41	53	3	1	CARDINAL
gsrj-41	54	1	one	CARDINAL
gsrj-41	54	2	two	CARDINAL
gsrj-41	54	3	a few months	DATE
gsrj-41	54	4	1	CARDINAL
gsrj-41	55	1	58	CARDINAL
gsrj-41	55	2	harrison et al.	PERSON
gsrj-41	55	3	2021)23	CARDINAL
gsrj-41	55	4	458,235	CARDINAL
gsrj-41	55	5	2021)20	CARDINAL
gsrj-41	55	6	2	CARDINAL
gsrj-41	56	1	11	CARDINAL
gsrj-41	56	2	1	CARDINAL
gsrj-41	56	3	27	CARDINAL
gsrj-41	57	1	88.89%	PERCENT
gsrj-41	57	2	14.81%	PERCENT
gsrj-41	57	3	7.40%	PERCENT
gsrj-41	58	1	24	CARDINAL
gsrj-41	58	2	88.89%	PERCENT
gsrj-41	59	1	16	CARDINAL
gsrj-41	59	2	59.25%	PERCENT
gsrj-41	59	3	16	DATE
gsrj-41	59	4	18	DATE
gsrj-41	59	5	20	DATE
gsrj-41	59	6	21	DATE
gsrj-41	59	7	22	DATE
gsrj-41	59	8	24	DATE
gsrj-41	59	9	27	DATE
gsrj-41	59	10	26	DATE
gsrj-41	59	11	28	DATE
gsrj-41	59	12	30	DATE
gsrj-41	59	13	31	DATE
gsrj-41	59	14	33	DATE
gsrj-41	59	15	36	DATE
gsrj-41	59	16	38	DATE
gsrj-41	59	17	39	DATE
gsrj-41	59	18	40	DATE
gsrj-41	59	19	2 (	PERCENT
gsrj-41	59	20	7.40%	PERCENT
gsrj-41	59	21	34	CARDINAL
gsrj-41	59	22	35	CARDINAL
gsrj-41	59	23	4	CARDINAL
gsrj-41	59	24	14.81%	PERCENT
gsrj-41	59	25	15	CARDINAL
gsrj-41	59	26	17	DATE
gsrj-41	59	27	25	DATE
gsrj-41	59	28	32	CARDINAL
gsrj-41	59	29	1	CARDINAL
gsrj-41	59	30	7.40%	PERCENT
gsrj-41	59	31	37	CARDINAL
gsrj-41	59	32	1	CARDINAL
gsrj-41	59	33	7.40%	PERCENT
gsrj-41	59	34	29	CARDINAL
gsrj-41	59	35	1	CARDINAL
gsrj-41	59	36	7.40%	PERCENT
gsrj-41	59	37	23	CARDINAL
gsrj-41	59	38	2 (	PERCENT
gsrj-41	59	39	14.81%	PERCENT
gsrj-41	59	40	1	CARDINAL
gsrj-41	59	41	7.40%	PERCENT
gsrj-41	59	42	19	CARDINAL
gsrj-41	59	43	1 (6.40%	PERCENT
gsrj-41	59	44	41	CARDINAL
gsrj-41	59	45	2	CARDINAL
gsrj-41	59	46	27	CARDINAL
gsrj-41	61	1	29.62%	PERCENT
gsrj-41	62	1	50 1	CARDINAL
gsrj-41	62	2	3.70%	PERCENT
gsrj-41	62	3	41	CARDINAL
gsrj-41	63	1	3.70%	PERCENT
gsrj-41	63	2	23	CARDINAL
gsrj-41	63	3	18.51%	PERCENT
gsrj-41	63	4	17	DATE
gsrj-41	63	5	18	DATE
gsrj-41	63	6	19	DATE
gsrj-41	63	7	29	DATE
gsrj-41	63	8	31	CARDINAL
gsrj-41	63	9	14.81%	PERCENT
gsrj-41	63	10	15	CARDINAL
gsrj-41	63	11	28	DATE
gsrj-41	63	12	33	DATE
gsrj-41	63	13	36	CARDINAL
gsrj-41	63	14	29.62%	PERCENT
gsrj-41	63	15	21	DATE
gsrj-41	63	16	27	DATE
gsrj-41	63	17	26	DATE
gsrj-41	63	18	32	DATE
gsrj-41	63	19	34	DATE
gsrj-41	63	20	38	DATE
gsrj-41	63	21	39	DATE
gsrj-41	63	22	40 5001-10000 2	CARDINAL
gsrj-41	63	23	7.40%	PERCENT
gsrj-41	63	24	16	CARDINAL
gsrj-41	63	25	35	CARDINAL
gsrj-41	63	26	22.22%	PERCENT
gsrj-41	63	27	20	DATE
gsrj-41	63	28	22	DATE
gsrj-41	63	29	24	DATE
gsrj-41	63	30	25	DATE
gsrj-41	63	31	30	DATE
gsrj-41	63	32	37 12	CARDINAL
gsrj-41	63	33	georgetown scientific research	ORG
gsrj-41	63	34	3.2	CARDINAL
gsrj-41	63	35	27	CARDINAL
gsrj-41	63	36	seven	CARDINAL
gsrj-41	63	37	25.9%	PERCENT
gsrj-41	63	38	the united states	GPE
gsrj-41	64	1	ten	CARDINAL
gsrj-41	64	2	37.0%	PERCENT
gsrj-41	64	3	the united states	GPE
gsrj-41	64	4	six	CARDINAL
gsrj-41	64	5	22.2%	PERCENT
gsrj-41	64	6	the united states	GPE
gsrj-41	65	1	four	CARDINAL
gsrj-41	65	2	14.8%	PERCENT
gsrj-41	65	3	one	CARDINAL
gsrj-41	65	4	3	CARDINAL
gsrj-41	66	1	3	CARDINAL
gsrj-41	66	2	27	CARDINAL
gsrj-41	67	1	u.s.	GPE
gsrj-41	67	2	37.0%	PERCENT
gsrj-41	67	3	u.s.	GPE
gsrj-41	67	4	25.9%	PERCENT
gsrj-41	67	5	u.s.	GPE
gsrj-41	67	6	22.2%	PERCENT
gsrj-41	67	7	14.8%	PERCENT
gsrj-41	68	1	n (%	PERCENT
gsrj-41	68	2	u.s.	GPE
gsrj-41	68	3	7	CARDINAL
gsrj-41	68	4	25.9%	PERCENT
gsrj-41	68	5	15	CARDINAL
gsrj-41	68	6	18	DATE
gsrj-41	68	7	20	DATE
gsrj-41	68	8	26	DATE
gsrj-41	68	9	25	DATE
gsrj-41	68	10	32	DATE
gsrj-41	68	11	38	DATE
gsrj-41	68	12	u.s. 10	GPE
gsrj-41	68	13	37.0%	PERCENT
gsrj-41	68	14	•	CARDINAL
gsrj-41	69	1	•	CARDINAL
gsrj-41	69	2	• employees22 •	DATE
gsrj-41	69	3	patients34 •	EVENT
gsrj-41	69	4	four	CARDINAL
gsrj-41	69	5	ibs36 •	ORG
gsrj-41	69	6	•	CARDINAL
gsrj-41	69	7	1240 •	LAW
gsrj-41	69	8	covid-19 vaccination27	ORG
gsrj-41	69	9	u.s. 6	DATE
gsrj-41	69	10	22.2%	PERCENT
gsrj-41	69	11	•	CARDINAL
gsrj-41	69	12	•	CARDINAL
gsrj-41	69	13	york28 •	ORG
gsrj-41	69	14	•	CARDINAL
gsrj-41	69	15	•	CARDINAL
gsrj-41	69	16	nyc39	DATE
gsrj-41	69	17	4	CARDINAL
gsrj-41	69	18	14.8%	PERCENT
gsrj-41	69	19	•	CARDINAL
gsrj-41	69	20	indiana16 •	ORG
gsrj-41	69	21	staff23 •	EVENT
gsrj-41	69	22	philadelphia24 •	ORG
gsrj-41	69	23	workers30 13	ORG
gsrj-41	69	24	georgetown scientific research	ORG
gsrj-41	69	25	3.3	CARDINAL
gsrj-41	69	26	57.14%	PERCENT
gsrj-41	70	1	16	CARDINAL
gsrj-41	70	2	twelve	CARDINAL
gsrj-41	70	3	two	CARDINAL
gsrj-41	70	4	two	CARDINAL
gsrj-41	70	5	4	CARDINAL
gsrj-41	71	1	only five	CARDINAL
gsrj-41	71	2	covid-19	PRODUCT
gsrj-41	71	3	18	CARDINAL
gsrj-41	71	4	30	CARDINAL
gsrj-41	71	5	18	CARDINAL
gsrj-41	71	6	36	DATE
gsrj-41	71	7	17 21.42%	PERCENT
gsrj-41	73	1	10.71%	PERCENT
gsrj-41	73	2	one	CARDINAL
gsrj-41	73	3	4	CARDINAL
gsrj-41	74	1	antivaccine attitudes	WORK_OF_ART
gsrj-41	74	2	4	CARDINAL
gsrj-41	75	1	new york’s	GPE
gsrj-41	75	2	23	CARDINAL
gsrj-41	75	3	covid-19	ORG
gsrj-41	75	4	u.s.	GPE
gsrj-41	75	5	one	CARDINAL
gsrj-41	75	6	14	CARDINAL
gsrj-41	75	7	4	CARDINAL
gsrj-41	75	8	28	CARDINAL
gsrj-41	76	1	57.14%	PERCENT
gsrj-41	76	2	21.42%	PERCENT
gsrj-41	76	3	14.28%	PERCENT
gsrj-41	76	4	3.57%	PERCENT
gsrj-41	76	5	3.57%	PERCENT
gsrj-41	77	1	n (%	PERCENT
gsrj-41	77	2	16	CARDINAL
gsrj-41	77	3	57.14%	PERCENT
gsrj-41	77	4	12 42.8%	PERCENT
gsrj-41	77	5	• 16, 17	DATE
gsrj-41	77	6	18	DATE
gsrj-41	77	7	22	DATE
gsrj-41	77	8	24	DATE
gsrj-41	77	9	27	DATE
gsrj-41	77	10	26	DATE
gsrj-41	77	11	28	DATE
gsrj-41	77	12	29	DATE
gsrj-41	77	13	34	DATE
gsrj-41	77	14	41 •	CARDINAL
gsrj-41	77	15	group15	ORG
gsrj-41	77	16	2 (	PERCENT
gsrj-41	77	17	7.14%	PERCENT
gsrj-41	77	18	• 30	DATE
gsrj-41	77	19	36	CARDINAL
gsrj-41	77	20	2	CARDINAL
gsrj-41	77	21	7.14%	PERCENT
gsrj-41	77	22	• 39	DATE
gsrj-41	77	23	40	CARDINAL
gsrj-41	77	24	6 (21.42%	PERCENT
gsrj-41	77	25	• 19	DATE
gsrj-41	77	26	group20 • phoenix adults21 •	ORG
gsrj-41	77	27	•	CARDINAL
gsrj-41	77	28	group35	ORG
gsrj-41	77	29	4 (14.28%	PERCENT
gsrj-41	77	30	3	CARDINAL
gsrj-41	77	31	10.71%	PERCENT
gsrj-41	77	32	• 31 •	DATE
gsrj-41	77	33	group20 •	ORG
gsrj-41	77	34	1 (	PERCENT
gsrj-41	77	35	3.57%	PERCENT
gsrj-41	77	36	•	CARDINAL
gsrj-41	77	37	1 (3.57%	PERCENT
gsrj-41	77	38	•	CARDINAL
gsrj-41	77	39	nyc adults21	LOC
gsrj-41	77	40	1 (3.57%	PERCENT
gsrj-41	77	41	•	CARDINAL
gsrj-41	77	42	refusers15	NORP
gsrj-41	77	43	4	CARDINAL
gsrj-41	77	44	hesitancy.15	ORG
gsrj-41	77	45	20	DATE
gsrj-41	77	46	25	DATE
gsrj-41	77	47	35 1	CARDINAL
gsrj-41	77	48	4	CARDINAL
gsrj-41	77	49	32	DATE
gsrj-41	77	50	37	DATE
gsrj-41	77	51	38 3.4	CARDINAL
gsrj-41	77	52	four	CARDINAL
gsrj-41	78	1	nineteen	CARDINAL
gsrj-41	79	1	20	CARDINAL
gsrj-41	79	2	25	DATE
gsrj-41	79	3	35	DATE
gsrj-41	80	1	fisher et al	PERSON
gsrj-41	81	1	2021	CARDINAL
gsrj-41	81	2	u.s.	GPE
gsrj-41	81	3	31.6%	PERCENT
gsrj-41	81	4	covid-19	PRODUCT
gsrj-41	81	5	10.8%	PERCENT
gsrj-41	82	1	15	CARDINAL
gsrj-41	82	2	georgetown scientific research journal	ORG
gsrj-41	82	3	34.1%	PERCENT
gsrj-41	82	4	21.7%).15 second	DATE
gsrj-41	83	1	2021	CARDINAL
gsrj-41	83	2	u.s.	GPE
gsrj-41	83	3	10.2%	PERCENT
gsrj-41	83	4	8.2%	PERCENT
gsrj-41	84	1	57.0%	PERCENT
gsrj-41	84	2	49.0%	PERCENT
gsrj-41	84	3	covid-19	PRODUCT
gsrj-41	84	4	third	ORDINAL
gsrj-41	84	5	2021	CARDINAL
gsrj-41	84	6	washington	GPE
gsrj-41	84	7	florida	GPE
gsrj-41	84	8	california	GPE
gsrj-41	84	9	texas	GPE
gsrj-41	84	10	45.4%	PERCENT
gsrj-41	84	11	9.8%	PERCENT
gsrj-41	85	1	54.8%	PERCENT
gsrj-41	86	1	four	CARDINAL
gsrj-41	86	2	twenty-seven	CARDINAL
gsrj-41	89	1	latkin et al	PERSON
gsrj-41	90	1	2021	CARDINAL
gsrj-41	90	2	covid-19	PRODUCT
gsrj-41	91	1	hispanic	NORP
gsrj-41	91	2	u.s.	GPE
gsrj-41	92	1	covid-19	PERSON
gsrj-41	92	2	dorman et al	PERSON
gsrj-41	93	1	2021	CARDINAL
gsrj-41	93	2	allen et al	PERSON
gsrj-41	94	1	2021	CARDINAL
gsrj-41	94	2	3.6	CARDINAL
gsrj-41	94	3	just over half	CARDINAL
gsrj-41	94	4	51.8%	PERCENT
gsrj-41	94	5	14	CARDINAL
gsrj-41	94	6	27	CARDINAL
gsrj-41	94	7	the federal drug administration	ORG
gsrj-41	94	8	the united states	GPE
gsrj-41	94	9	december 11, 2020	DATE
gsrj-41	96	1	10	CARDINAL
gsrj-41	96	2	27	CARDINAL
gsrj-41	96	3	37.0%	PERCENT
gsrj-41	97	1	eua	PERSON
gsrj-41	97	2	fda	ORG
gsrj-41	98	1	fda	ORG
gsrj-41	98	2	covid-19	PERSON
gsrj-41	98	3	fda	ORG
gsrj-41	98	4	2019).42	CARDINAL
gsrj-41	98	5	three	CARDINAL
gsrj-41	98	6	eua	PERSON
gsrj-41	99	1	5	CARDINAL
gsrj-41	100	1	16	CARDINAL
gsrj-41	100	2	5	CARDINAL
gsrj-41	100	3	fda eua	PERSON
gsrj-41	100	4	covid-19	PRODUCT
gsrj-41	100	5	dec 11, 2020	DATE
gsrj-41	100	6	27	CARDINAL
gsrj-41	101	1	fda eua	PERSON
gsrj-41	101	2	51.8%	PERCENT
gsrj-41	101	3	37.0%	PERCENT
gsrj-41	101	4	11.1%	PERCENT
gsrj-41	102	1	2	CARDINAL
gsrj-41	102	2	19 1	CARDINAL
gsrj-41	102	3	may 2020	DATE
gsrj-41	102	4	3.7	CARDINAL
gsrj-41	102	5	eleven	CARDINAL
gsrj-41	102	6	the fda eua	ORG
gsrj-41	102	7	seven	CARDINAL
gsrj-41	102	8	three	CARDINAL
gsrj-41	102	9	three	CARDINAL
gsrj-41	103	1	nine	CARDINAL
gsrj-41	103	2	eua	PERSON
gsrj-41	103	3	eight	CARDINAL
gsrj-41	103	4	two	CARDINAL
gsrj-41	104	1	three	CARDINAL
gsrj-41	104	2	two	CARDINAL
gsrj-41	105	1	41	CARDINAL
gsrj-41	106	1	fda eua	PERSON
gsrj-41	106	2	cdc	ORG
gsrj-41	107	1	4	CARDINAL
gsrj-41	107	2	4.1	CARDINAL
gsrj-41	107	3	us	GPE
gsrj-41	107	4	the united states	GPE
gsrj-41	108	1	35.5%	PERCENT
gsrj-41	108	2	covid-19	PERSON
gsrj-41	108	3	february 15	DATE
gsrj-41	108	4	2021.6	CARDINAL
gsrj-41	108	5	24%	PERCENT
gsrj-41	108	6	covid-19	DATE
gsrj-41	108	7	1	CARDINAL
gsrj-41	109	1	18-24 years old	DATE
gsrj-41	109	2	25-39 years old	DATE
gsrj-41	109	3	3).8	CARDINAL
gsrj-41	109	4	covid-19	PRODUCT
gsrj-41	109	5	16	CARDINAL
gsrj-41	109	6	27	CARDINAL
gsrj-41	109	7	57.14%	PERCENT
gsrj-41	109	8	3	CARDINAL
gsrj-41	110	1	american	NORP
gsrj-41	110	2	hesitancy.17	ORG
gsrj-41	110	3	18	CARDINAL
gsrj-41	110	4	30	CARDINAL
gsrj-41	110	5	30	DATE
gsrj-41	110	6	17	DATE
gsrj-41	110	7	n (%	PERCENT
gsrj-41	110	8	14	DATE
gsrj-41	110	9	51.8%	PERCENT
gsrj-41	110	10	15	CARDINAL
gsrj-41	110	11	16	DATE
gsrj-41	110	12	18	DATE
gsrj-41	110	13	21	DATE
gsrj-41	110	14	24	DATE
gsrj-41	110	15	27	DATE
gsrj-41	110	16	29	DATE
gsrj-41	110	17	30	DATE
gsrj-41	110	18	31	DATE
gsrj-41	110	19	32	DATE
gsrj-41	110	20	33	DATE
gsrj-41	110	21	35	DATE
gsrj-41	110	22	37	DATE
gsrj-41	110	23	38	DATE
gsrj-41	110	24	10	DATE
gsrj-41	110	25	37.0%	PERCENT
gsrj-41	110	26	17	CARDINAL
gsrj-41	110	27	20	DATE
gsrj-41	110	28	22	DATE
gsrj-41	110	29	23	DATE
gsrj-41	110	30	25	DATE
gsrj-41	110	31	28	DATE
gsrj-41	110	32	34	DATE
gsrj-41	110	33	36	DATE
gsrj-41	110	34	39	DATE
gsrj-41	110	35	40	DATE
gsrj-41	110	36	3	CARDINAL
gsrj-41	110	37	11.1%	PERCENT
gsrj-41	110	38	19	DATE
gsrj-41	110	39	26	DATE
gsrj-41	110	40	41 17	CARDINAL
gsrj-41	110	41	18	CARDINAL
gsrj-41	111	1	internet.34	LAW
gsrj-41	111	2	41	CARDINAL
gsrj-41	111	3	26	CARDINAL
gsrj-41	111	4	covid-19	PRODUCT
gsrj-41	111	5	u.s.	GPE
gsrj-41	112	1	the united states	GPE
gsrj-41	113	1	15	CARDINAL
gsrj-41	115	1	covid-19	ORG
gsrj-41	115	2	43 4.2	CARDINAL
gsrj-41	115	3	covid-19	ORG
gsrj-41	115	4	rate.32	NORP
gsrj-41	115	5	covid-19	PRODUCT
gsrj-41	115	6	americans	NORP
gsrj-41	116	1	31	CARDINAL
gsrj-41	116	2	u.s.	GPE
gsrj-41	116	3	americans	NORP
gsrj-41	116	4	covid-19 vaccines.31	GPE
gsrj-41	117	1	bogart et al	PERSON
gsrj-41	118	1	2021	CARDINAL
gsrj-41	118	2	americans	NORP
gsrj-41	118	3	covid-19	PRODUCT
gsrj-41	119	1	u.s.	GPE
gsrj-41	120	1	4.3	CARDINAL
gsrj-41	120	2	u.s.	GPE
gsrj-41	121	1	five	CARDINAL
gsrj-41	121	2	covid-19	PRODUCT
gsrj-41	121	3	u.s.	GPE
gsrj-41	121	4	covid-19	PRODUCT
gsrj-41	121	5	us	GPE
gsrj-41	122	1	18	CARDINAL
gsrj-41	122	2	two weeks	DATE
gsrj-41	123	1	about 24 hours	TIME
gsrj-41	124	1	covid-19	PERSON
gsrj-41	125	1	others.47	ORG
gsrj-41	125	2	48	CARDINAL
gsrj-41	125	3	covid-19	PRODUCT
gsrj-41	125	4	covid-19	PRODUCT
gsrj-41	125	5	fatigue.17 1	ORG
gsrj-41	125	6	49	CARDINAL
gsrj-41	125	7	covid-19	PERSON
gsrj-41	127	1	2	CARDINAL
gsrj-41	129	1	september	DATE
gsrj-41	129	2	2021	CARDINAL
gsrj-41	129	3	unvaccinated.50	CARDINAL
gsrj-41	129	4	51	CARDINAL
gsrj-41	129	5	u.s.	GPE
gsrj-41	129	6	americans	NORP
gsrj-41	129	7	covid-19	ORG
gsrj-41	130	1	cdc	ORG
gsrj-41	130	2	fda	ORG
gsrj-41	131	1	efforts.52	ORG
gsrj-41	131	2	3	CARDINAL
gsrj-41	131	3	u.s.	GPE
gsrj-41	132	1	4	CARDINAL
gsrj-41	133	1	general.44	NORP
gsrj-41	134	1	19	CARDINAL
gsrj-41	134	2	6	CARDINAL
gsrj-41	134	3	covid-19 vaccinations &	ORG
gsrj-41	134	4	u.s.	GPE
gsrj-41	135	1	4.4	CARDINAL
gsrj-41	135	2	covid-19	PRODUCT
gsrj-41	136	1	covid-19	ORG
gsrj-41	139	1	covid-19	PRODUCT
gsrj-41	140	1	covid-19	ORG
gsrj-41	141	1	fda	ORG
gsrj-41	142	1	4.4	CARDINAL
gsrj-41	145	1	5	CARDINAL
gsrj-41	145	2	u.s.	GPE
gsrj-41	146	1	•	CARDINAL
gsrj-41	146	2	•	CARDINAL
gsrj-41	146	3	•	CARDINAL
gsrj-41	146	4	•	CARDINAL
gsrj-41	146	5	•	CARDINAL
gsrj-41	146	6	•	CARDINAL
gsrj-41	146	7	•	CARDINAL
gsrj-41	146	8	•	CARDINAL
gsrj-41	146	9	•	CARDINAL
gsrj-41	146	10	•	CARDINAL
gsrj-41	146	11	•	CARDINAL
gsrj-41	146	12	•	CARDINAL
gsrj-41	146	13	•	CARDINAL
gsrj-41	146	14	•	CARDINAL
gsrj-41	146	15	20	CARDINAL
gsrj-41	146	16	georgetown scientific research journal	ORG
gsrj-41	146	17	covid-19	ORG
gsrj-41	146	18	american	NORP
gsrj-41	152	1	covid-19	ORG
gsrj-41	153	1	ma	PERSON
gsrj-41	154	1	cdc	ORG
gsrj-41	154	2	atlanta	GPE
gsrj-41	154	3	ga	ORG
gsrj-41	155	1	margaret baker	PERSON
gsrj-41	155	2	georgetown university’s	ORG
gsrj-41	156	1	1	CARDINAL
gsrj-41	157	1	cdc	ORG
gsrj-41	157	2	2022	CARDINAL
gsrj-41	160	1	2	CARDINAL
gsrj-41	161	1	2021	CARDINAL
gsrj-41	162	1	fda	ORG
gsrj-41	162	2	covid-19	PRODUCT
gsrj-41	163	1	fda	ORG
gsrj-41	163	2	fda	ORG
gsrj-41	164	1	3	CARDINAL
gsrj-41	165	1	2021	CARDINAL
gsrj-41	166	1	covid-19	PRODUCT
gsrj-41	168	1	4	CARDINAL
gsrj-41	168	2	covid-19	PERSON
gsrj-41	169	1	2021	CARDINAL
gsrj-41	169	2	february 15	DATE
gsrj-41	169	3	2022	CARDINAL
gsrj-41	169	4	5	CARDINAL
gsrj-41	169	5	naleway	PERSON
gsrj-41	169	6	a. l.	PERSON
gsrj-41	169	7	2021	CARDINAL
gsrj-41	170	1	covid-19	PERSON
gsrj-41	170	2	covid-19	ORG
gsrj-41	170	3	oregon	GPE
gsrj-41	170	4	washington	GPE
gsrj-41	170	5	july 4	DATE
gsrj-41	170	6	september 25	DATE
gsrj-41	170	7	2021	DATE
gsrj-41	171	1	mmwr	PERSON
gsrj-41	172	1	weekly	DATE
gsrj-41	172	2	70	DATE
gsrj-41	173	1	6	CARDINAL
gsrj-41	174	1	cdc	ORG
gsrj-41	175	1	2022	CARDINAL
gsrj-41	175	2	february 15	DATE
gsrj-41	178	1	7	DATE
gsrj-41	179	1	cdc	ORG
gsrj-41	180	1	2019, october 30	DATE
gsrj-41	183	1	https://www.cdc.gov/vaccines/partners/vaccinatewith-confidence.html 8	DATE
gsrj-41	184	1	cdc	ORG
gsrj-41	185	1	2022	CARDINAL
gsrj-41	185	2	february 15	DATE
gsrj-41	186	1	covid-19	DATE
gsrj-41	186	2	the united states	GPE
gsrj-41	190	1	cdc	ORG
gsrj-41	191	1	2022	CARDINAL
gsrj-41	191	2	february 15	DATE
gsrj-41	192	1	covid-19	DATE
gsrj-41	194	1	10	CARDINAL
gsrj-41	195	1	cdc	ORG
gsrj-41	196	1	2022	CARDINAL
gsrj-41	196	2	february 15	DATE
gsrj-41	197	1	covid-19	PERSON
gsrj-41	200	1	21	CARDINAL
gsrj-41	200	2	11	CARDINAL
gsrj-41	201	1	covid-19	CARDINAL
gsrj-41	201	2	cdc	ORG
gsrj-41	202	1	2021, november 30	DATE
gsrj-41	204	1	12	CARDINAL
gsrj-41	205	1	covid-19	PERSON
gsrj-41	206	1	2021	CARDINAL
gsrj-41	208	1	november 14, 2021	DATE
gsrj-41	208	2	https://www.mayoclinic.org/diseasesconditions/coronavirus/in-depth/herd-immunityand-coronavirus/art-20486808 13	ORG
gsrj-41	209	1	2021, september 13	DATE
gsrj-41	210	1	johns hopkins bloomberg school of public health	ORG
gsrj-41	211	1	14	CARDINAL
gsrj-41	213	1	n.d.	GPE
gsrj-41	214	1	february 15	DATE
gsrj-41	214	2	2022	DATE
gsrj-41	214	3	15	CARDINAL
gsrj-41	215	1	fisher	ORG
gsrj-41	215	2	k. a.	PERSON
gsrj-41	215	3	bloomstone	ORG
gsrj-41	215	4	s. j.	PERSON
gsrj-41	215	5	j., crawford	PERSON
gsrj-41	215	6	s.	GPE
gsrj-41	215	7	fouayzi, h., & mazor	ORG
gsrj-41	215	8	k. m.	PERSON
gsrj-41	215	9	2020	DATE
gsrj-41	216	1	u.s.	GPE
gsrj-41	217	1	173(12	CARDINAL
gsrj-41	217	2	964–973	CARDINAL
gsrj-41	218	1	16	CARDINAL
gsrj-41	219	1	unroe	ORG
gsrj-41	219	2	k. t.	PERSON
gsrj-41	219	3	evans	GPE
gsrj-41	219	4	r.	NORP
gsrj-41	219	5	l.	GPE
gsrj-41	219	6	rusyniak	PERSON
gsrj-41	219	7	d., & blackburn	ORG
gsrj-41	219	8	j.	PERSON
gsrj-41	219	9	2021	CARDINAL
gsrj-41	220	1	covid-19	PRODUCT
gsrj-41	221	1	american	NORP
gsrj-41	221	2	69(3	CARDINAL
gsrj-41	221	3	593–599	CARDINAL
gsrj-41	222	1	https://doi.org/10.1111/jgs.17022 17	ORG
gsrj-41	223	1	m., gurung, a.	PERSON
gsrj-41	223	2	anglewicz	GPE
gsrj-41	223	3	subedi	GPE
gsrj-41	223	4	c., ali	GPE
gsrj-41	223	5	ibrahim	PERSON
gsrj-41	223	6	haider	PERSON
gsrj-41	223	7	m.	PERSON
gsrj-41	223	8	j.	PERSON
gsrj-41	223	9	thang	PERSON
gsrj-41	223	10	j.	PERSON
gsrj-41	223	11	wang	PERSON
gsrj-41	223	12	s.	PERSON
gsrj-41	223	13	kim	PERSON
gsrj-41	223	14	c.	GPE
gsrj-41	223	15	kimball	GPE
gsrj-41	223	16	s. l.	PERSON
gsrj-41	223	17	karaki	GPE
gsrj-41	223	18	abouagila	PERSON
gsrj-41	223	19	m., & yun	ORG
gsrj-41	223	20	k.	PERSON
gsrj-41	223	21	2021	CARDINAL
gsrj-41	224	1	covid-19	PRODUCT
gsrj-41	224	2	the united states	GPE
gsrj-41	225	1	washington	GPE
gsrj-41	225	2	d.c	GPE
gsrj-41	225	3	1974	DATE
gsrj-41	225	4	136(6	CARDINAL
gsrj-41	225	5	774–781	CARDINAL
gsrj-41	225	6	18	CARDINAL
gsrj-41	225	7	solís arce	ORG
gsrj-41	225	8	j. s.	PERSON
gsrj-41	225	9	warren	PERSON
gsrj-41	225	10	s. s.	PERSON
gsrj-41	225	11	meriggi	PERSON
gsrj-41	225	12	n. f.	PERSON
gsrj-41	225	13	scacco, a.	ORG
gsrj-41	225	14	mcmurry	GPE
gsrj-41	225	15	m., syunyaev	ORG
gsrj-41	225	16	malik	GPE
gsrj-41	225	17	a. a.	PERSON
gsrj-41	225	18	aboutajdine	GPE
gsrj-41	225	19	s.	PERSON
gsrj-41	225	20	anigo	PERSON
gsrj-41	225	21	d., armand	GPE
gsrj-41	225	22	asad	PERSON
gsrj-41	225	23	m., augsburg	PERSON
gsrj-41	225	24	b.	GPE
gsrj-41	225	25	m.	PERSON
gsrj-41	225	26	g. e.	PERSON
gsrj-41	225	27	bancalari	GPE
gsrj-41	225	28	a.	PERSON
gsrj-41	225	29	m.	PERSON
gsrj-41	225	30	borisova	PERSON
gsrj-41	225	31	s. b.	PERSON
gsrj-41	225	32	2021	CARDINAL
gsrj-41	226	1	covid-19	PERSON
gsrj-41	226	2	middleincome	PERSON
gsrj-41	227	1	1385	CARDINAL
gsrj-41	227	2	1394	DATE
gsrj-41	228	1	19	CARDINAL
gsrj-41	228	2	ehde	ORG
gsrj-41	228	3	d. m.	PERSON
gsrj-41	228	4	roberts	PERSON
gsrj-41	228	5	m. k.	PERSON
gsrj-41	228	6	humbert	PERSON
gsrj-41	228	7	a. t.	PERSON
gsrj-41	228	8	t. e., & alschuler	ORG
gsrj-41	228	9	k. n.	PERSON
gsrj-41	228	10	2021	CARDINAL
gsrj-41	229	1	covid-19	PERSON
gsrj-41	229	2	the united states	GPE
gsrj-41	229	3	2021	CARDINAL
gsrj-41	230	1	54	DATE
gsrj-41	230	2	103163	DATE
gsrj-41	231	1	20	CARDINAL
gsrj-41	231	2	k. h.	PERSON
gsrj-41	231	3	saeed	PERSON
gsrj-41	231	4	s.	PERSON
gsrj-41	231	5	bradley	PERSON
gsrj-41	231	6	b.	PERSON
gsrj-41	231	7	eshun-wilson	GPE
gsrj-41	231	8	i.	GPE
gsrj-41	231	9	mody, a., & geng	ORG
gsrj-41	231	10	e.	PERSON
gsrj-41	231	11	2021	CARDINAL
gsrj-41	232	1	covid-19	ORG
gsrj-41	232	2	the united states	GPE
gsrj-41	233	1	america	GPE
gsrj-41	235	1	21	CARDINAL
gsrj-41	236	1	m., seale, h.	PERSON
gsrj-41	236	2	chughtai	PERSON
gsrj-41	236	3	a. a.	PERSON
gsrj-41	236	4	d., & macintyre	ORG
gsrj-41	236	5	c. r.	PERSON
gsrj-41	236	6	2021	CARDINAL
gsrj-41	237	1	five	CARDINAL
gsrj-41	237	2	the united states	GPE
gsrj-41	237	3	united kingdom	GPE
gsrj-41	237	4	australia	GPE
gsrj-41	238	1	2	CARDINAL
gsrj-41	240	1	w. c.	PERSON
gsrj-41	240	2	rubinstein	ORG
gsrj-41	240	3	a., & mejia	ORG
gsrj-41	240	4	r.	PERSON
gsrj-41	240	5	2021	CARDINAL
gsrj-41	241	1	covid-19	PRODUCT
gsrj-41	241	2	january-may 2021	DATE
gsrj-41	241	3	18-64 year old	DATE
gsrj-41	242	1	24, 101569	DATE
gsrj-41	243	1	23	CARDINAL
gsrj-41	244	1	harrison	PERSON
gsrj-41	244	2	j.	PERSON
gsrj-41	244	3	mor	GPE
gsrj-41	244	4	2021	CARDINAL
gsrj-41	245	1	covid-19	PERSON
gsrj-41	246	1	the american medical directors association	ORG
gsrj-41	246	2	22(6	CARDINAL
gsrj-41	246	3	1133–1137	CARDINAL
gsrj-41	247	1	24	DATE
gsrj-41	247	2	momplaisir	PERSON
gsrj-41	247	3	f. m.	PERSON
gsrj-41	247	4	kuter	PERSON
gsrj-41	247	5	b. j.	PERSON
gsrj-41	247	6	f.	PERSON
gsrj-41	247	7	browne	PERSON
gsrj-41	247	8	s.	GPE
gsrj-41	247	9	h.	PERSON
gsrj-41	247	10	k. a.	PERSON
gsrj-41	247	11	22	CARDINAL
gsrj-41	247	12	i.	PERSON
gsrj-41	247	13	faig	PERSON
gsrj-41	247	14	w.	PERSON
gsrj-41	247	15	shen	GPE
gsrj-41	247	16	a. k.	PERSON
gsrj-41	247	17	j.	PERSON
gsrj-41	247	18	2021	CARDINAL
gsrj-41	248	1	covid-19	PRODUCT
gsrj-41	248	2	2	CARDINAL
gsrj-41	249	1	4(8	CARDINAL
gsrj-41	250	1	1931 25	DATE
gsrj-41	251	1	nguyen	PERSON
gsrj-41	251	2	k. h.	PERSON
gsrj-41	251	3	srivastav	GPE
gsrj-41	251	4	a.	PERSON
gsrj-41	251	5	williams	PERSON
gsrj-41	251	6	w.	PERSON
gsrj-41	251	7	m. c.	PERSON
gsrj-41	251	8	jorgensen	GPE
gsrj-41	251	9	c., abad	PERSON
gsrj-41	251	10	n., & singleton	ORG
gsrj-41	251	11	j. a.	PERSON
gsrj-41	252	1	september	DATE
gsrj-41	252	2	december 2020	DATE
gsrj-41	253	1	american journal of transplantation :	ORG
gsrj-41	253	2	american	NORP
gsrj-41	253	3	american	NORP
gsrj-41	253	4	21(4	DATE
gsrj-41	253	5	1650	CARDINAL
gsrj-41	253	6	1656	CARDINAL
gsrj-41	254	1	26	CARDINAL
gsrj-41	255	1	mondal	PERSON
gsrj-41	255	2	a., & su	ORG
gsrj-41	255	3	2021	CARDINAL
gsrj-41	256	1	covid-19	PRODUCT
gsrj-41	257	1	198	CARDINAL
gsrj-41	257	2	252–259	CARDINAL
gsrj-41	258	1	27	CARDINAL
gsrj-41	258	2	nguyen	PERSON
gsrj-41	258	3	k. h.	PERSON
gsrj-41	258	4	nguyen, k.	PERSON
gsrj-41	258	5	corlin	GPE
gsrj-41	258	6	l.	GPE
gsrj-41	258	7	allen	PERSON
gsrj-41	258	8	j. d., & chung	PERSON
gsrj-41	258	9	2021a	DATE
gsrj-41	259	1	united states	GPE
gsrj-41	259	2	january 6 march 29, 2021	DATE
gsrj-41	260	1	53(1	CARDINAL
gsrj-41	260	2	1419–1428	CARDINAL
gsrj-41	261	1	28	CARDINAL
gsrj-41	262	1	iadarola	ORG
gsrj-41	262	2	s., siegel	PERSON
gsrj-41	262	3	j. f.	PERSON
gsrj-41	262	4	gao	PERSON
gsrj-41	262	5	q., mcgrath	PERSON
gsrj-41	262	6	k., & bonuck	ORG
gsrj-41	262	7	k. a.	PERSON
gsrj-41	262	8	2021	CARDINAL
gsrj-41	263	1	covid-19	PRODUCT
gsrj-41	263	2	new york	GPE
gsrj-41	264	1	101178	DATE
gsrj-41	266	1	29	CARDINAL
gsrj-41	267	1	scott	ORG
gsrj-41	267	2	e. m.	PERSON
gsrj-41	267	3	stein	GPE
gsrj-41	267	4	r.	NORP
gsrj-41	267	5	brown	PERSON
gsrj-41	267	6	m. f.	PERSON
gsrj-41	267	7	j., scott	ORG
gsrj-41	267	8	e. m.	PERSON
gsrj-41	267	9	o. k.	PERSON
gsrj-41	267	10	2021	CARDINAL
gsrj-41	268	1	ohio	GPE
gsrj-41	269	1	1058	CARDINAL
gsrj-41	269	2	1063	CARDINAL
gsrj-41	270	1	30	CARDINAL
gsrj-41	271	1	meyer	ORG
gsrj-41	271	2	m. n.	PERSON
gsrj-41	271	3	t., & rosica	ORG
gsrj-41	271	4	2021	CARDINAL
gsrj-41	272	1	covid-19	PRODUCT
gsrj-41	273	1	4(3	CARDINAL
gsrj-41	274	1	344 31	DATE
gsrj-41	275	1	bogart	ORG
gsrj-41	275	2	l. m.	PERSON
gsrj-41	275	3	gandhi	PERSON
gsrj-41	275	4	klein	GPE
gsrj-41	275	5	d. j.	PERSON
gsrj-41	275	6	t. l.	PERSON
gsrj-41	275	7	s., & ojikutu	ORG
gsrj-41	275	8	2021	CARDINAL
gsrj-41	276	1	covid-19	PERSON
gsrj-41	276	2	americans	NORP
gsrj-41	277	1	the national medical association	ORG
gsrj-41	277	2	9684(21)00082-1	CARDINAL
gsrj-41	279	1	32	CARDINAL
gsrj-41	280	1	c. a.	PERSON
gsrj-41	280	2	dayton	GPE
gsrj-41	280	3	l.	GPE
gsrj-41	280	4	g.	PERSON
gsrj-41	280	5	b., & kong	ORG
gsrj-41	280	6	x.	GPE
gsrj-41	280	7	2021	CARDINAL
gsrj-41	281	1	covid-19	ORG
gsrj-41	281	2	us	GPE
gsrj-41	282	1	plos one	PERSON
gsrj-41	282	2	16(2	CARDINAL
gsrj-41	283	1	https://doi.org/10.1371/journal.pone.0246970 33	PERSON
gsrj-41	284	1	j., mcknight	PERSON
gsrj-41	284	2	m.	PERSON
gsrj-41	284	3	m.	PERSON
gsrj-41	284	4	k. c.	PERSON
gsrj-41	284	5	m.	PERSON
gsrj-41	284	6	2021	CARDINAL
gsrj-41	285	1	covid-19	PRODUCT
gsrj-41	285	2	tennessee	GPE
gsrj-41	286	1	american journal of health	ORG
gsrj-41	286	2	american	NORP
gsrj-41	286	3	879–889	CARDINAL
gsrj-41	287	1	34	CARDINAL
gsrj-41	287	2	r. m.	PERSON
gsrj-41	287	3	torres	PERSON
gsrj-41	287	4	j. r.	PERSON
gsrj-41	287	5	chang, a. m., haggins	PERSON
gsrj-41	287	6	a. n.	PERSON
gsrj-41	287	7	s. a.	PERSON
gsrj-41	287	8	o'laughlin	PERSON
gsrj-41	287	9	k. n.	PERSON
gsrj-41	287	10	anderson	PERSON
gsrj-41	287	11	e.	GPE
gsrj-41	287	12	miller	PERSON
gsrj-41	287	13	d. g.	PERSON
gsrj-41	287	14	wilkerson	GPE
gsrj-41	287	15	r. g.	PERSON
gsrj-41	287	16	caldwell	ORG
gsrj-41	287	17	m., lim	PERSON
gsrj-41	287	18	s. c.	PERSON
gsrj-41	287	19	a. s.	PERSON
gsrj-41	287	20	baumann	GPE
gsrj-41	287	21	b. m.	PERSON
gsrj-41	287	22	graterol	ORG
gsrj-41	287	23	j.	PERSON
gsrj-41	287	24	b., &	ORG
gsrj-41	287	25	2021	CARDINAL
gsrj-41	288	1	covid-19	DATE
gsrj-41	289	1	502–510	CARDINAL
gsrj-41	291	1	026 35	CARDINAL
gsrj-41	292	1	m. f.	PERSON
gsrj-41	292	2	piasecki	PERSON
gsrj-41	292	3	a. m.	PERSON
gsrj-41	292	4	strick	GPE
gsrj-41	292	5	l. b.	PERSON
gsrj-41	292	6	tyagi	ORG
gsrj-41	292	7	patel	PERSON
gsrj-41	292	8	r.	NORP
gsrj-41	292	9	r., & furukawa	ORG
gsrj-41	292	10	n. w.	PERSON
gsrj-41	292	11	2021	CARDINAL
gsrj-41	293	1	covid-19	PRODUCT
gsrj-41	293	2	four	CARDINAL
gsrj-41	293	3	september-december 2020	DATE
gsrj-41	294	1	mmwr	PERSON
gsrj-41	295	1	weekly	DATE
gsrj-41	295	2	23	CARDINAL
gsrj-41	295	3	473–477	CARDINAL
gsrj-41	296	1	36	CARDINAL
gsrj-41	297	1	r. s.	PERSON
gsrj-41	297	2	mcclure	GPE
gsrj-41	297	3	e., marcus	PERSON
gsrj-41	297	4	j.	GPE
gsrj-41	297	5	r. w.	PERSON
gsrj-41	297	6	hamilton	PERSON
gsrj-41	297	7	m. j., &	PERSON
gsrj-41	297	8	j. r.	PERSON
gsrj-41	297	9	2021	CARDINAL
gsrj-41	298	1	covid-19	DATE
gsrj-41	299	1	the american gastroenterological association	ORG
gsrj-41	299	2	19(8	DATE
gsrj-41	300	1	37	DATE
gsrj-41	301	1	c.	PERSON
gsrj-41	301	2	perera	GPE
gsrj-41	301	3	condon	GPE
gsrj-41	301	4	qian	PERSON
gsrj-41	301	5	j., kalk	ORG
gsrj-41	301	6	k., & diazdeleon	ORG
gsrj-41	301	7	2021	CARDINAL
gsrj-41	302	1	covid-19	ORG
gsrj-41	303	1	journal of community health	ORG
gsrj-41	303	2	46(5	CARDINAL
gsrj-41	303	3	1013–1019	DATE
gsrj-41	304	1	38	DATE
gsrj-41	305	1	allen	PERSON
gsrj-41	305	2	j. d.	PERSON
gsrj-41	305	3	feng	PERSON
gsrj-41	305	4	w.	GPE
gsrj-41	305	5	corlin	GPE
gsrj-41	305	6	l.	GPE
gsrj-41	305	7	t.,	GPE
gsrj-41	305	8	acevedo, a.	ORG
gsrj-41	305	9	schildkraut	PRODUCT
gsrj-41	305	10	d.	NORP
gsrj-41	305	11	ladin	PERSON
gsrj-41	305	12	k.	PERSON
gsrj-41	305	13	t. j.	PERSON
gsrj-41	305	14	2021	CARDINAL
gsrj-41	306	1	covid-19	ORG
gsrj-41	307	1	u.s.	GPE
gsrj-41	307	2	may-june 2020	DATE
gsrj-41	308	1	24	CARDINAL
gsrj-41	308	2	101494	DATE
gsrj-41	309	1	39	DATE
gsrj-41	310	1	c. a.	GPE
gsrj-41	310	2	borrell	GPE
gsrj-41	310	3	l. n.	PERSON
gsrj-41	310	4	kimball	GPE
gsrj-41	310	5	s.	PERSON
gsrj-41	310	6	m. l.	PERSON
gsrj-41	310	7	s. a.	PERSON
gsrj-41	310	8	nash	PERSON
gsrj-41	310	9	2021a	DATE
gsrj-41	311	1	covid-19	PRODUCT
gsrj-41	311	2	new york city	GPE
gsrj-41	312	1	5082–5086	CARDINAL
gsrj-41	313	1	40	CARDINAL
gsrj-41	314	1	c. a.	GPE
gsrj-41	314	2	borrell	GPE
gsrj-41	314	3	l. n.	PERSON
gsrj-41	314	4	kimball	GPE
gsrj-41	314	5	s.	PERSON
gsrj-41	314	6	m. l.	PERSON
gsrj-41	314	7	rane	GPE
gsrj-41	314	8	m.	PERSON
gsrj-41	314	9	s. a.	PERSON
gsrj-41	314	10	nash	PERSON
gsrj-41	314	11	2021b	CARDINAL
gsrj-41	315	1	2019	DATE
gsrj-41	315	2	united states	GPE
gsrj-41	316	1	the journal of pediatrics	ORG
gsrj-41	316	2	237	CARDINAL
gsrj-41	316	3	292–297	CARDINAL
gsrj-41	317	1	41	CARDINAL
gsrj-41	318	1	teherani	ORG
gsrj-41	318	2	m.	PERSON
gsrj-41	318	3	banskota	GPE
gsrj-41	318	4	s.	GPE
gsrj-41	318	5	camacho-gonzalez	PERSON
gsrj-41	318	6	a.	PERSON
gsrj-41	318	7	smith, a.	ORG
gsrj-41	318	8	anderson	PERSON
gsrj-41	318	9	e. j.	PERSON
gsrj-41	318	10	c. m.	PERSON
gsrj-41	318	11	d'orleans	NORP
gsrj-41	318	12	a. l.	PERSON
gsrj-41	318	13	lu, a., & jaggi	ORG
gsrj-41	318	14	2021	CARDINAL
gsrj-41	320	1	1049	CARDINAL
gsrj-41	321	1	https://doi.org/10.3390/vaccines9091049	ORG
gsrj-41	321	2	42	CARDINAL
gsrj-41	323	1	2019, july 9	DATE
gsrj-41	325	1	u.s.	GPE
gsrj-41	325	2	food and drug administration	ORG
gsrj-41	325	3	fda	ORG
gsrj-41	326	1	43	DATE
gsrj-41	326	2	piltch-loeb	PERSON
gsrj-41	326	3	r.	NORP
gsrj-41	326	4	savoia	GPE
gsrj-41	326	5	b.	PERSON
gsrj-41	326	6	t., kayyem	GPE
gsrj-41	326	7	j.	PERSON
gsrj-41	326	8	m.	PERSON
gsrj-41	326	9	2021	CARDINAL
gsrj-41	327	1	covid-19	PRODUCT
gsrj-41	328	1	plos one	PERSON
gsrj-41	328	2	16(5	CARDINAL
gsrj-41	329	1	44	CARDINAL
gsrj-41	330	1	b. o.	PERSON
gsrj-41	330	2	stephenson	PERSON
gsrj-41	330	3	k. e.	PERSON
gsrj-41	330	4	mayer	PERSON
gsrj-41	330	5	k. h.	PERSON
gsrj-41	330	6	k. m.	PERSON
gsrj-41	330	7	2021	CARDINAL
gsrj-41	331	1	covid-19	ORG
gsrj-41	332	1	american journal of public health	ORG
gsrj-41	332	2	111(3	CARDINAL
gsrj-41	332	3	366–368	CARDINAL
gsrj-41	333	1	45	DATE
gsrj-41	334	1	cdc	ORG
gsrj-41	334	2	2021	CARDINAL
gsrj-41	335	1	covid-19	PERSON
gsrj-41	337	1	46	DATE
gsrj-41	338	1	cdc	ORG
gsrj-41	338	2	2021	CARDINAL
gsrj-41	339	1	covid-19	PRODUCT
gsrj-41	341	1	47	DATE
gsrj-41	342	1	cdc	ORG
gsrj-41	342	2	2020	DATE
gsrj-41	343	1	covid-19	PERSON
gsrj-41	345	1	48	DATE
gsrj-41	346	1	xie	PERSON
gsrj-41	346	2	xu	PERSON
gsrj-41	346	3	al-aly	PERSON
gsrj-41	346	4	z.	PERSON
gsrj-41	346	5	2022	CARDINAL
gsrj-41	348	1	49	DATE
gsrj-41	349	1	chou	PERSON
gsrj-41	349	2	w. s.	PERSON
gsrj-41	349	3	2020	DATE
gsrj-41	350	1	covid-19	ORG
gsrj-41	351	1	1718–1722	CARDINAL
gsrj-41	352	1	50	CARDINAL
gsrj-41	353	1	tufekci	PERSON
gsrj-41	353	2	z.	PERSON
gsrj-41	353	3	2021, october 15	DATE
gsrj-41	354	1	24	CARDINAL
gsrj-41	354	2	the new york times	ORG
gsrj-41	355	1	https://www.nytimes.com/2021/10/15/opinion/c ovid-vaccines-unvaccinated.html 51	PERSON
gsrj-41	356	1	kff covid-19	PERSON
gsrj-41	356	2	kff	ORG
gsrj-41	357	1	2021	CARDINAL
gsrj-41	358	1	november 10, 2021	DATE
gsrj-41	358	2	https://www.kff.org/coronavirus-covid19/dashboard/kff-covid-19-vaccine-monitordashboard/ 52	ORG
gsrj-41	359	1	cdc	ORG
gsrj-41	360	1	2019, march 11	DATE
gsrj-41	361	1	53	DATE
gsrj-41	362	1	haverfield mc	PERSON
gsrj-41	362	2	shaw jg	PERSON
gsrj-41	365	1	doi:10.1001	GPE
gsrj-41	365	2	54	DATE
gsrj-41	365	3	philadelphia	GPE
gsrj-41	365	4	t. c. h.	GPE
gsrj-41	366	1	2015, march 17	DATE
gsrj-41	368	1	philadelphia	GPE
gsrj-41	369	1	25	CARDINAL
gsrj-41	370	1	covid-19 united states	GPE
gsrj-41	370	2	fda eua	PERSON
gsrj-41	370	3	dec 11, 2020	DATE
gsrj-41	371	1	fisher	PERSON
gsrj-41	371	2	2020	DATE
gsrj-41	372	1	u.s. adults15	GPE
gsrj-41	372	2	covid-19	ORG
gsrj-41	372	3	the united states	GPE
gsrj-41	373	1	16	CARDINAL
gsrj-41	374	1	991	CARDINAL
gsrj-41	374	2	approximately 1000	CARDINAL
gsrj-41	374	3	approximately 97%	PERCENT
gsrj-41	374	4	u.s.	GPE
gsrj-41	375	1	16.1%	PERCENT
gsrj-41	375	2	31.6%	PERCENT
gsrj-41	375	3	10.8%	PERCENT
gsrj-41	375	4	72.1%	PERCENT
gsrj-41	376	1	57.3%	PERCENT
gsrj-41	376	2	22.3%	PERCENT
gsrj-41	376	3	56.6%	PERCENT
gsrj-41	376	4	32.5%	PERCENT
gsrj-41	376	5	34.1%	PERCENT
gsrj-41	376	6	21.7%	PERCENT
gsrj-41	376	7	26	CARDINAL
gsrj-41	377	1	2021	CARDINAL
gsrj-41	378	1	covid-19	PRODUCT
gsrj-41	378	2	2019	DATE
gsrj-41	378	3	covid-19	ORG
gsrj-41	378	4	the indiana department of health	ORG
gsrj-41	379	1	november of 2020	DATE
gsrj-41	379	2	indiana	GPE
gsrj-41	379	3	8,243	CARDINAL
gsrj-41	379	4	23,232	CARDINAL
gsrj-41	379	5	november 2020	DATE
gsrj-41	379	6	first	ORDINAL
gsrj-41	379	7	55%	PERCENT
gsrj-41	379	8	44%	PERCENT
gsrj-41	380	1	70%	PERCENT
gsrj-41	381	1	34%	PERCENT
gsrj-41	381	2	20%	PERCENT
gsrj-41	381	3	12%	PERCENT
gsrj-41	382	1	2021	CARDINAL
gsrj-41	383	1	covid-19	PRODUCT
gsrj-41	383	2	covid-19	PRODUCT
gsrj-41	383	3	the united states	GPE
gsrj-41	384	1	covid-19	ORG
gsrj-41	384	2	the united states	GPE
gsrj-41	385	1	us	GPE
gsrj-41	385	2	december 2020	DATE
gsrj-41	385	3	january 2021	DATE
gsrj-41	385	4	435	CARDINAL
gsrj-41	385	5	us	GPE
gsrj-41	385	6	70.3%	PERCENT
gsrj-41	385	7	7.6%	PERCENT
gsrj-41	385	8	22.1%	PERCENT
gsrj-41	385	9	covid-19	PRODUCT
gsrj-41	385	10	71.3%	PERCENT
gsrj-41	385	11	covid-19	PRODUCT
gsrj-41	385	12	12.4%	PERCENT
gsrj-41	385	13	8.5%	PERCENT
gsrj-41	386	1	27	CARDINAL
gsrj-41	386	2	solís arce	ORG
gsrj-41	386	3	2021	CARDINAL
gsrj-41	387	1	covid-19	PERSON
gsrj-41	387	2	russia	GPE
gsrj-41	387	3	dec 4-5, 2020	DATE
gsrj-41	387	4	462	CARDINAL
gsrj-41	387	5	u.s.	GPE
gsrj-41	387	6	1313	CARDINAL
gsrj-41	387	7	us	GPE
gsrj-41	387	8	64.6%	PERCENT
gsrj-41	387	9	79.3%	PERCENT
gsrj-41	387	10	46.8%	PERCENT
gsrj-41	387	11	covid-19	ORG
gsrj-41	387	12	39.3%	PERCENT
gsrj-41	388	1	2021	CARDINAL
gsrj-41	389	1	covid-19	PERSON
gsrj-41	389	2	the united states	GPE
gsrj-41	389	3	202119	DATE
gsrj-41	389	4	covid-19	PRODUCT
gsrj-41	389	5	2	CARDINAL
gsrj-41	389	6	april/may 2020	DATE
gsrj-41	389	7	jan/feb 2021 1	DATE
gsrj-41	389	8	359	CARDINAL
gsrj-41	389	9	20.3%	PERCENT
gsrj-41	390	1	90%	PERCENT
gsrj-41	391	1	2021	CARDINAL
gsrj-41	392	1	covid-19	ORG
gsrj-41	392	2	states20	ORG
gsrj-41	392	3	covid-19	PRODUCT
gsrj-41	392	4	u.s.	GPE
gsrj-41	392	5	the us census bureau’s	ORG
gsrj-41	392	6	jan-march 2021	DATE
gsrj-41	392	7	459,235	CARDINAL
gsrj-41	392	8	2021	CARDINAL
gsrj-41	392	9	140 million	CARDINAL
gsrj-41	392	10	10.2%	PERCENT
gsrj-41	392	11	8.2%	PERCENT
gsrj-41	392	12	28	CARDINAL
gsrj-41	392	13	57.0%	PERCENT
gsrj-41	392	14	52.1%	PERCENT
gsrj-41	392	15	26.7%	PERCENT
gsrj-41	392	16	covid-19	PRODUCT
gsrj-41	392	17	49.0%	PERCENT
gsrj-41	392	18	40%	PERCENT
gsrj-41	393	1	2021	CARDINAL
gsrj-41	394	1	covid-19	PRODUCT
gsrj-41	394	2	five	CARDINAL
gsrj-41	394	3	us	GPE
gsrj-41	394	4	uk	GPE
gsrj-41	394	5	covid-19	ORG
gsrj-41	394	6	five	CARDINAL
gsrj-41	394	7	covid-19	CARDINAL
gsrj-41	394	8	us	GPE
gsrj-41	394	9	uk	GPE
gsrj-41	394	10	australia	GPE
gsrj-41	395	1	dynata’s	ORG
gsrj-41	395	2	julyseptember 2020	ORG
gsrj-41	396	1	18	DATE
gsrj-41	396	2	sydney	GPE
gsrj-41	396	3	melbourne	GPE
gsrj-41	396	4	london	GPE
gsrj-41	396	5	new york city	GPE
gsrj-41	397	1	1204	DATE
gsrj-41	397	2	nyc 500	DATE
gsrj-41	397	3	phoenix	GPE
gsrj-41	397	4	nyc	LOC
gsrj-41	397	5	42%	PERCENT
gsrj-41	397	6	nyc	LOC
gsrj-41	397	7	phoenix	GPE
gsrj-41	397	8	30%	PERCENT
gsrj-41	398	1	2021	CARDINAL
gsrj-41	399	1	covid-19	PRODUCT
gsrj-41	399	2	january-may 2021	DATE
gsrj-41	399	3	18-64 year old	DATE
gsrj-41	399	4	jan to may 2021	DATE
gsrj-41	399	5	18-64 years	DATE
gsrj-41	399	6	covid-19	ORG
gsrj-41	399	7	3,179,174	CARDINAL
gsrj-41	399	8	january 6-may 19	DATE
gsrj-41	399	9	2021	DATE
gsrj-41	400	1	55375	CARDINAL
gsrj-41	400	2	over half	CARDINAL
gsrj-41	400	3	51.7%	PERCENT
gsrj-41	400	4	covid-19	ORG
gsrj-41	400	5	51.3%	PERCENT
gsrj-41	400	6	15%	PERCENT
gsrj-41	400	7	third	ORDINAL
gsrj-41	400	8	45.1%	PERCENT
gsrj-41	400	9	44.6%	PERCENT
gsrj-41	400	10	29	CARDINAL
gsrj-41	400	11	35.2%	PERCENT
gsrj-41	400	12	harrison	PERSON
gsrj-41	401	1	2021	CARDINAL
gsrj-41	402	1	covid-19	PERSON
gsrj-41	402	2	covid-19	PRODUCT
gsrj-41	402	3	58	CARDINAL
gsrj-41	402	4	dec 2020	DATE
gsrj-41	402	5	58	CARDINAL
gsrj-41	402	6	u.s.	GPE
gsrj-41	403	1	momplaisir	PERSON
gsrj-41	403	2	2021	CARDINAL
gsrj-41	404	1	covid-19	PRODUCT
gsrj-41	404	2	2	CARDINAL
gsrj-41	404	3	covid-19	PERSON
gsrj-41	405	1	2	CARDINAL
gsrj-41	405	2	3-week	DATE
gsrj-41	405	3	november	DATE
gsrj-41	405	4	december 2020	DATE
gsrj-41	406	1	12,034	CARDINAL
gsrj-41	406	2	2	CARDINAL
gsrj-41	406	3	philadelphia	GPE
gsrj-41	406	4	34.5%	PERCENT
gsrj-41	406	5	5440	CARDINAL
gsrj-41	406	6	4737	DATE
gsrj-41	406	7	87.1%	PERCENT
gsrj-41	406	8	4306	DATE
gsrj-41	406	9	79.2%	PERCENT
gsrj-41	406	10	4091	CARDINAL
gsrj-41	406	11	75.2%	PERCENT
gsrj-41	407	1	nguyen	PERSON
gsrj-41	407	2	2021	CARDINAL
gsrj-41	408	1	covid-19	DATE
gsrj-41	408	2	us	GPE
gsrj-41	408	3	sept and dec 2020	DATE
gsrj-41	408	4	cdc	ORG
gsrj-41	408	5	sept and dec 2020	DATE
gsrj-41	408	6	3541	CARDINAL
gsrj-41	408	7	oct and 2033	DATE
gsrj-41	408	8	65	DATE
gsrj-41	408	9	december	DATE
gsrj-41	408	10	32.1%	PERCENT
gsrj-41	408	11	29.8%	PERCENT
gsrj-41	408	12	30	CARDINAL
gsrj-41	408	13	united states	GPE
gsrj-41	408	14	september	DATE
gsrj-41	408	15	december 202025	DATE
gsrj-41	408	16	14.5%	PERCENT
gsrj-41	408	17	12.5%	PERCENT
gsrj-41	408	18	covid-19	ORG
gsrj-41	408	19	10.4%	PERCENT
gsrj-41	409	1	2021	CARDINAL
gsrj-41	410	1	covid-19	PRODUCT
gsrj-41	410	2	covid-19	PRODUCT
gsrj-41	411	1	covid-19	PRODUCT
gsrj-41	412	1	between may 2020	DATE
gsrj-41	412	2	jan 2021	DATE
gsrj-41	412	3	2978	CARDINAL
gsrj-41	412	4	covid-19	ORG
gsrj-41	413	1	covid-19	ORG
gsrj-41	413	2	cdc	ORG
gsrj-41	414	1	18.9%	PERCENT
gsrj-41	414	2	84.2%	PERCENT
gsrj-41	414	3	44.4%	PERCENT
gsrj-41	415	1	51.0%	PERCENT
gsrj-41	415	2	only 5.4%	PERCENT
gsrj-41	416	1	31	CARDINAL
gsrj-41	416	2	georgetown scientific research journal	ORG
gsrj-41	417	1	2021	CARDINAL
gsrj-41	418	1	covid-19	GPE
gsrj-41	418	2	united states	GPE
gsrj-41	418	3	january 6 – march 29, 202127	DATE
gsrj-41	418	4	u.s.	GPE
gsrj-41	419	1	jan to march 2021	DATE
gsrj-41	420	1	75,000	CARDINAL
gsrj-41	420	2	u.s.	GPE
gsrj-41	420	3	6.4-7.5%	PERCENT
gsrj-41	420	4	january to march	DATE
gsrj-41	420	5	more than five	CARDINAL
gsrj-41	420	6	early january to late march	DATE
gsrj-41	421	1	late march	DATE
gsrj-41	421	2	54.5%	PERCENT
gsrj-41	421	3	50.9%	PERCENT
gsrj-41	421	4	35.5%	PERCENT
gsrj-41	421	5	56%	PERCENT
gsrj-41	421	6	51.1%	PERCENT
gsrj-41	421	7	25.4	CARDINAL
gsrj-41	421	8	25	CARDINAL
gsrj-41	421	9	46.5%	PERCENT
gsrj-41	421	10	covid-19	ORG
gsrj-41	421	11	47.9	CARDINAL
gsrj-41	421	12	40.1	CARDINAL
gsrj-41	421	13	7.6%	PERCENT
gsrj-41	421	14	late march	DATE
gsrj-41	422	1	2021	CARDINAL
gsrj-41	423	1	covid-19	PRODUCT
gsrj-41	423	2	new york	GPE
gsrj-41	423	3	covid-19	PRODUCT
gsrj-41	423	4	ny	GPE
gsrj-41	423	5	new york’s	GPE
gsrj-41	423	6	825	CARDINAL
gsrj-41	423	7	25%	PERCENT
gsrj-41	423	8	16%	PERCENT
gsrj-41	423	9	15%	PERCENT
gsrj-41	423	10	14%	PERCENT
gsrj-41	423	11	14%	PERCENT
gsrj-41	423	12	32	CARDINAL
gsrj-41	423	13	georgetown scientific research journal	ORG
gsrj-41	423	14	community28	PERSON
gsrj-41	424	1	jan-feb 2021	DATE
gsrj-41	424	2	92%	PERCENT
gsrj-41	424	3	74%	PERCENT
gsrj-41	426	1	scott	ORG
gsrj-41	426	2	2021	CARDINAL
gsrj-41	427	1	ohio	GPE
gsrj-41	427	2	amish revisited29	PERSON
gsrj-41	427	3	a decade ago	DATE
gsrj-41	427	4	amish	NORP
gsrj-41	427	5	covid-19	PRODUCT
gsrj-41	428	1	april 2020	DATE
gsrj-41	428	2	1000	CARDINAL
gsrj-41	428	3	amish	NORP
gsrj-41	428	4	391	CARDINAL
gsrj-41	428	5	ohio	GPE
gsrj-41	428	6	75%	PERCENT
gsrj-41	428	7	83.9%	PERCENT
gsrj-41	428	8	46%	PERCENT
gsrj-41	432	1	meyer	ORG
gsrj-41	432	2	2021	CARDINAL
gsrj-41	433	1	covid-19	ORG
gsrj-41	433	2	covid-19	PRODUCT
gsrj-41	433	3	administrativ e	ORG
gsrj-41	433	4	dec 2020 before 16292	DATE
gsrj-41	433	5	u.s.	GPE
gsrj-41	433	6	68.5%	PERCENT
gsrj-41	433	7	28.4%	PERCENT
gsrj-41	433	8	16.3%	PERCENT
gsrj-41	433	9	90.3%	PERCENT
gsrj-41	433	10	6569	CARDINAL
gsrj-41	433	11	44.3%	PERCENT
gsrj-41	433	12	3226	CARDINAL
gsrj-41	433	13	33	CARDINAL
gsrj-41	434	1	21.1%	PERCENT
gsrj-41	434	2	1539	CARDINAL
gsrj-41	434	3	fda	ORG
gsrj-41	435	1	more than one-half	CARDINAL
gsrj-41	435	2	57.4%	PERCENT
gsrj-41	435	3	4187	CARDINAL
gsrj-41	436	1	bogart	PERSON
gsrj-41	436	2	2021	CARDINAL
gsrj-41	437	1	covid-19	PERSON
gsrj-41	437	2	americans31	PERSON
gsrj-41	437	3	american	NORP
gsrj-41	437	4	nov-dec 2020	DATE
gsrj-41	437	5	207	CARDINAL
gsrj-41	437	6	american	NORP
gsrj-41	437	7	american	NORP
gsrj-41	437	8	35%	PERCENT
gsrj-41	437	9	covid-19	PRODUCT
gsrj-41	437	10	40%	PERCENT
gsrj-41	437	11	25%	PERCENT
gsrj-41	438	1	95%	PERCENT
gsrj-41	438	2	2.2	CARDINAL
gsrj-41	438	3	1.23.9	CARDINAL
gsrj-41	438	4	.007	CARDINAL
gsrj-41	438	5	95%	PERCENT
gsrj-41	438	6	0.6	CARDINAL
gsrj-41	438	7	0.4	CARDINAL
gsrj-41	438	8	.001	CARDINAL
gsrj-41	439	1	2021	CARDINAL
gsrj-41	440	1	covid-19	ORG
gsrj-41	440	2	us32	PRODUCT
gsrj-41	440	3	american	NORP
gsrj-41	440	4	may 2020	DATE
gsrj-41	440	5	1,056	CARDINAL
gsrj-41	440	6	53.6%	PERCENT
gsrj-41	440	7	16.7%	PERCENT
gsrj-41	440	8	29.7%	PERCENT
gsrj-41	440	9	covid-19	PRODUCT
gsrj-41	440	10	16.7%	PERCENT
gsrj-41	441	1	34	CARDINAL
gsrj-41	441	2	one	CARDINAL
gsrj-41	443	1	2021	CARDINAL
gsrj-41	444	1	covid-19	PRODUCT
gsrj-41	444	2	tennessee	GPE
gsrj-41	444	3	adults33	ORG
gsrj-41	444	4	2019	DATE
gsrj-41	444	5	covid-19	ORG
gsrj-41	445	1	june 2020	DATE
gsrj-41	445	2	tn	ORG
gsrj-41	445	3	18-64	DATE
gsrj-41	445	4	1,000	CARDINAL
gsrj-41	445	5	62.9%	PERCENT
gsrj-41	445	6	54.1%	PERCENT
gsrj-41	445	7	three	CARDINAL
gsrj-41	445	8	covid-19	ORG
gsrj-41	446	1	32.1%	PERCENT
gsrj-41	446	2	24.6%	PERCENT
gsrj-41	446	3	23.2%	PERCENT
gsrj-41	447	1	approximately onethird	CARDINAL
gsrj-41	447	2	34.4%	PERCENT
gsrj-41	447	3	only 21.4%	PERCENT
gsrj-41	448	1	2021	CARDINAL
gsrj-41	449	1	covid-19	DATE
gsrj-41	449	2	study34	GPE
gsrj-41	449	3	disproportiona te covid-19	PERSON
gsrj-41	449	4	dec 2020	DATE
gsrj-41	449	5	march 2021	DATE
gsrj-41	449	6	15	CARDINAL
gsrj-41	449	7	14	CARDINAL
gsrj-41	449	8	2,301	CARDINAL
gsrj-41	449	9	89.4%	PERCENT
gsrj-41	449	10	61%	PERCENT
gsrj-41	449	11	3	CARDINAL
gsrj-41	449	12	65%	PERCENT
gsrj-41	449	13	35	CARDINAL
gsrj-41	450	1	covid-19	PRODUCT
gsrj-41	451	1	47%	PERCENT
gsrj-41	451	2	24%	PERCENT
gsrj-41	452	1	fourth	ORDINAL
gsrj-41	452	2	fourth	ORDINAL
gsrj-41	452	3	covid-19	ORG
gsrj-41	453	1	2021	CARDINAL
gsrj-41	454	1	covid-19	PRODUCT
gsrj-41	454	2	us	GPE
gsrj-41	454	3	sept to dec 2020	DATE
gsrj-41	454	4	3	CARDINAL
gsrj-41	454	5	13	CARDINAL
gsrj-41	454	6	4	CARDINAL
gsrj-41	454	7	washington	GPE
gsrj-41	454	8	florida	GPE
gsrj-41	454	9	california	GPE
gsrj-41	454	10	texas	GPE
gsrj-41	454	11	5,110	CARDINAL
gsrj-41	454	12	64.2%	PERCENT
gsrj-41	454	13	45.4%	PERCENT
gsrj-41	454	14	9.8%	PERCENT
gsrj-41	454	15	54.8%	PERCENT
gsrj-41	454	16	31.0%	PERCENT
gsrj-41	455	1	covid-19	PRODUCT
gsrj-41	455	2	20.1%	PERCENT
gsrj-41	456	1	2021	CARDINAL
gsrj-41	457	1	covid-19	DATE
gsrj-41	457	2	dec to jan 2021	DATE
gsrj-41	457	3	906	CARDINAL
gsrj-41	457	4	ibs	ORG
gsrj-41	457	5	boston	GPE
gsrj-41	457	6	ma & from	ORG
gsrj-41	457	7	8.1%	PERCENT
gsrj-41	457	8	covid-19	DATE
gsrj-41	457	9	80.9%	PERCENT
gsrj-41	457	10	60.0%	PERCENT
gsrj-41	458	1	36	CARDINAL
gsrj-41	458	2	georgetown scientific research journal	ORG
gsrj-41	458	3	64.4%	PERCENT
gsrj-41	458	4	70.1%	PERCENT
gsrj-41	458	5	first	ORDINAL
gsrj-41	458	6	62.2%	PERCENT
gsrj-41	458	7	55.6%	PERCENT
gsrj-41	459	1	approximately 70%	PERCENT
gsrj-41	460	1	2021	CARDINAL
gsrj-41	461	1	covid-19	ORG
gsrj-41	461	2	sample37	PERSON
gsrj-41	461	3	californian	NORP
gsrj-41	461	4	oct and nov 2020	DATE
gsrj-41	461	5	26,324	CARDINAL
gsrj-41	461	6	california	GPE
gsrj-41	461	7	5c	CARDINAL
gsrj-41	461	8	allen	PERSON
gsrj-41	462	1	2021	CARDINAL
gsrj-41	463	1	covid-19	ORG
gsrj-41	464	1	u.s.	GPE
gsrj-41	464	2	covid-19	PRODUCT
gsrj-41	464	3	may-june 2020 before 1219	DATE
gsrj-41	464	4	us	GPE
gsrj-41	464	5	64%	PERCENT
gsrj-41	464	6	17.7%	PERCENT
gsrj-41	464	7	24.2%	PERCENT
gsrj-41	464	8	37	CARDINAL
gsrj-41	464	9	may-june 202038	DATE
gsrj-41	464	10	american	NORP
gsrj-41	464	11	78.1%	PERCENT
gsrj-41	464	12	5.0%	PERCENT
gsrj-41	464	13	covid-19	PRODUCT
gsrj-41	464	14	77.2%	PERCENT
gsrj-41	464	15	4.8%	PERCENT
gsrj-41	465	1	74%	PERCENT
gsrj-41	465	2	45.3%	PERCENT
gsrj-41	466	1	42.4%	PERCENT
gsrj-41	467	1	half	CARDINAL
gsrj-41	467	2	49%	PERCENT
gsrj-41	467	3	38	CARDINAL
gsrj-41	468	1	2021	CARDINAL
gsrj-41	469	1	covid-19	PRODUCT
gsrj-41	469	2	new york	GPE
gsrj-41	469	3	nyc	LOC
gsrj-41	469	4	march 9april 11	DATE
gsrj-41	469	5	2021	CARDINAL
gsrj-41	469	6	1,119	CARDINAL
gsrj-41	469	7	under 12	DATE
gsrj-41	469	8	nyc	LOC
gsrj-41	469	9	61.9%	PERCENT
gsrj-41	469	10	14.8%	PERCENT
gsrj-41	469	11	23.3%	PERCENT
gsrj-41	469	12	81.2%	PERCENT
gsrj-41	469	13	covid-19	PERSON
gsrj-41	469	14	21.7%	PERCENT
gsrj-41	469	15	16.6%	PERCENT
gsrj-41	469	16	9.5%	PERCENT
gsrj-41	470	1	2021	CARDINAL
gsrj-41	471	1	2019	DATE
gsrj-41	471	2	united states	ORG
gsrj-41	471	3	parents40	ORG
gsrj-41	471	4	u.s.	GPE
gsrj-41	471	5	march 2021	DATE
gsrj-41	471	6	2074	CARDINAL
gsrj-41	471	7	under 12	DATE
gsrj-41	471	8	49.4%	PERCENT
gsrj-41	471	9	25.6%	PERCENT
gsrj-41	471	10	25.0%	PERCENT
gsrj-41	471	11	78.2%	PERCENT
gsrj-41	471	12	23.0%	PERCENT
gsrj-41	471	13	11.2%	PERCENT
gsrj-41	471	14	8.5%	PERCENT
gsrj-41	471	15	teherani	ORG
gsrj-41	472	1	2021	CARDINAL
gsrj-41	473	1	u.s.	GPE
gsrj-41	473	2	2	CARDINAL
gsrj-41	473	3	19	CARDINAL
gsrj-41	473	4	april-nov 2020 &	DATE
gsrj-41	473	5	2021 1 before & 1	DATE
gsrj-41	473	6	102	CARDINAL
gsrj-41	473	7	april-nov 2020	DATE
gsrj-41	473	8	& 45	DATE
gsrj-41	473	9	dec-jan 2021	DATE
gsrj-41	473	10	51%	PERCENT
gsrj-41	473	11	44%	PERCENT
gsrj-41	473	12	45%	PERCENT
gsrj-41	473	13	43%	PERCENT
gsrj-41	473	14	12%	PERCENT
gsrj-41	473	15	24	CARDINAL
gsrj-41	473	16	50%	PERCENT
gsrj-41	473	17	37.5%	PERCENT
gsrj-41	473	18	16.67%	PERCENT
gsrj-41	473	19	39	CARDINAL
gsrj-41	473	20	georgetown scientific research journal	ORG
gsrj-41	473	21	covid-19	PERSON
gsrj-41	473	22	40 41	CARDINAL
gsrj-41	473	23	covid-19	PRODUCT
gsrj-41	473	24	the united states	GPE
gsrj-41	473	25	american	NORP
gsrj-41	473	26	cook county	GPE
gsrj-41	473	27	illinois	GPE
gsrj-41	474	1	d.c.	GPE